C. Ha

发表

Image-Guided Radiation Therapy for Renal Cell Carcinoma

Y. Li, G. Swanson, C. Ha, 2013 .

Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.

Terry L. Smith, R. Kurzrock, M. Duvic, 2003, Journal of the American Academy of Dermatology.

Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.

S. Tucker, J. Cox, F. Cabanillas, 2001, International journal of radiation oncology, biology, physics.

Radiation-induced injury to the visual pathway.

A. Garden, K. Ang, S. Tucker, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Patient dosimetry for total body irradiation using single‐use MOSFET detectors

R. Lane, M. Gillin, S. Woo, 2008, Journal of applied clinical medical physics.

Agreement rates among single photon emission computed tomography using gallium‐67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome

J. Cox, P. Allen, E. Kim, 2000, Cancer.

MULTIPLE MODALITY TREATMENT OF CARCINOMA CELLS WITH Pt(Rh‐123)2 PLUS X‐RAY PLUS LIGHT

A. Oseroff, B. Teicher, T. Herman, 1992, Photochemistry and photobiology.

A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents

B. Teicher, T. Herman, G. Ara, 1992, Journal of Cancer Research and Clinical Oncology.

Image-Guided Radiation Therapy in Gynecology Applications

C. Ha, T. Eng, D. Baseman, 2013 .

Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy

P. Mclaughlin, F. Cabanillas, J. Cox, 2003, Cancer.

Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens

J. Epstein, G. Swanson, O. Kryvenko, 2015, The Prostate.

Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP).

L. Fuller, J. Cox, M. Meistrich, 2000, International journal of radiation oncology, biology, physics.

Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.

Z. Liao, S. Tucker, L. Fuller, 1998, International journal of radiation oncology, biology, physics.

Postoperative radiotherapy for cutaneous melanoma of the head and neck region.

A. Garden, R. Weber, L. Peters, 1994, International journal of radiation oncology, biology, physics.

Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.

L. Fuller, J. Cox, B. Brown, 1997, International journal of radiation oncology, biology, physics.

Image-guided radiation therapy in lymphoma management

C. Ha, T. Eng, 2015, Radiation oncology journal.

Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017

Charles R. Thomas, P. Spellman, P. Okunieff, 2018, Clinical Cancer Research.

Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia

M. Qazilbash, D. Couriel, R. Champlin, 2006, Bone Marrow Transplantation.

HODGKIN LYMPHOMA — FAVORABLE PROGNOSIS STAGE I AND II

R. Advani, Sonali M. Smith, C. Flowers, 2016 .

ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma.

R. Advani, Sonali M. Smith, C. Flowers, 2016, Oncology.

Stages I-III follicular lymphoma: role of CT of the abdomen and pelvis in follow-up studies.

J. Cox, F. Cabanillas, C. Ha, 1999, Radiology.

The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis

S. Jhavar, G. Swanson, G. Jensen, 2022, Clinical and translational radiation oncology.

Human lymphoma cells develop resistance to radiation in the presence of astrocytes in vitro.

O. Riesterer, M. Story, U. Raju, 2011, Anticancer research.

Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma.

H. Kantarjian, J. Cortes, S. Verstovsek, 2004, Blood.

The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum.

J. Manning, J. Cox, F. Cabanillas, 2000, International journal of radiation oncology, biology, physics.

Clinical course of solitary extramedullary plasmacytoma.

J. Cox, D. Weber, C. Ha, 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Primary parotid lymphoma: the effect of International Prognostic Index on outcome.

P. Mclaughlin, J. Cox, F. Cabanillas, 1997, Leukemia & lymphoma.

US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALL.

J. Radich, F. Appelbaum, H. Kantarjian, 2016, Blood advances.

Localized non‐Hodgkin lymphoma involving the thyroid gland

J. Cox, L. Medeiros, R. Wilder, 2001, Cancer.

Primary non-Hodgkin lymphoma of the small bowel.

L. Fuller, J. Cox, P. Allen, 1999, Radiology.

Lymphoma of the nasal cavity and paranasal sinuses

J. Cox, V. Kavadi, C. Ha, 1997, Cancer.

Mycosis Fungoides with Follicular Mucinosis Displaying Aggressive Tumor-Stage Transformation

M. Duvic, C. Ha, N. Apisarnthanarax, 2003, American journal of clinical dermatology.

Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.

J. Cox, D. Weber, C. Ha, 1998, International journal of radiation oncology, biology, physics.

2834 : Breast Dose Reduction in Women Undergoing Mediastinal Radiotherapy Using a Custom Prone Immobilization Device

R. Kudchadker, R. Wilder, S. Kirsner, 2006 .

p53-Based Strategy for Protection of Bone Marrow From Y-90 Ibritumomab Tiuxetan.

Zhi-Min Yuan, S. Ganapathy, C. Ha, 2015, International journal of radiation oncology, biology, physics.

Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective study.

S. Tucker, P. Mclaughlin, J. Cox, 2001, International journal of radiation oncology, biology, physics.

Stage III follicular lymphoma: long-term follow-up and patterns of failure.

S. Tucker, P. Mclaughlin, J. Cox, 2003, International journal of radiation oncology, biology, physics.

Second Malignancies After Chemotherapy and Radiotherapy for Hodgkin Disease

Maria A. Rodriguez, L. Levy, E. Atkinson, 2004, American journal of clinical oncology.

Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816

Sonali M. Smith, J. Friedberg, J. Leonard, 2020, Leukemia & lymphoma.

Localized primary non-Hodgkin lymphoma of the breast.

J. Cox, F. Cabanillas, C. Ha, 1998, American journal of clinical oncology.

A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma.

C. Pinnix, J. Westin, S. Neelapu, 2020, International journal of radiation oncology, biology, physics.

A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.

Maria A. Rodriguez, S. Tucker, P. Mclaughlin, 2003, International journal of radiation oncology, biology, physics.

Long-Term F ollow-Up o f a P rospective S tudy o f C ombined Modality T herapy f or S tage I -II I ndolent N on-Hodgkin's Lymphoma

Maria A. Rodriguez, L. Fuller, P. Mclaughlin, 2003 .

Molecular Response of Follicular Lymphoma to Cyclophosphamide, Doxorubicin, Vincristine, Prednisone C(H)OP or COP‐Based Therapy as Measured by Polymerase Chain Reaction Evidence of Translocation (14;18)(q32;q21)

S. Tucker, P. Mclaughlin, F. Cabanillas, 2004, Cancer journal.

Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.

L. Fuller, P. Mclaughlin, J. Cox, 1999, International journal of radiation oncology, biology, physics.

The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia

H. Kantarjian, J. Cox, C. Koller, 2004, Cancer.

B-Cell Non-Hodgkin’s Lymphoma of the Stomach

C. Ha, T. Eng, 2010 .

Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy

J. Manning, F. Cabanillas, J. Cox, 2001, Cancer.

Clinical Outcomes of Spatially Fractionated GRID Radiotherapy in the Treatment of Bulky Tumors of the Head and Neck

C. Ha, J. I. Choi, T. Eng, 2019, Cureus.

Imexon augments sensitivity of human lymphoma cells to ionizing radiation: in vitro experimental study.

O. Riesterer, M. Story, L. Milas, 2009, Anticancer research.

Solitary plasmacytomas

J. Shah, L. Medeiros, R. Orlowski, 2011, Cancer.

Outcome and Prognostic Factors After Definitive Radiation Therapy

J. Shah, L. Medeiros, R. Orlowski, 2011 .

Fludarabine allows dose reduction for total body irradiation in pediatric hematopoietic stem cell transplantation.

J. Antolak, A. Mahajan, S. Woo, 2007, International journal of radiation oncology, biology, physics.

Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.

L. Fuller, F. Cabanillas, F. Cabanillas, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Enhancement by perflusion emulsion (Oxygent) and carbogen breathing of the tumor growth delay of the FSaIIC fibrosarcoma after treatment with antitumor alkylating agents.

B. Teicher, T. Herman, G. Ara, 1992, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.

Hematologic recovery after central lymphatic irradiation for patients with stage I–III follicular lymphoma

S. Tucker, P. Mclaughlin, F. Cabanillas, 2001, Cancer.

Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report.

P. Mclaughlin, J. Cox, F. Cabanillas, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Role of radiation therapy to the brain in leukemic patients with cranial nerve palsies in the absence of radiological findings.

J. Cox, C. Koller, C. Ha, 1999, Leukemia & lymphoma.

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia.

M. Andreeff, H. Kantarjian, J. Cortes, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Utilization of thermoluminescent dosimetry in total skin electron beam radiotherapy of mycosis fungoides.

J. Antolak, C. Ha, J. Cundiff, 1998, International journal of radiation oncology, biology, physics.

Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies

L. Worth, D. Petropoulos, C. Mullen, 2006, Bone Marrow Transplantation.

Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation.

R. Salem, G. Steele, R. Bleday, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Nonnasopharyngeal lymphoepithelioma of the head and neck

K. Ang, W. Morrison, C. Ha, 1998, Cancer.

Outcomes Using Doxorubicin-Based Chemotherapy with or without Radiotherapy for Early-Stage Peripheral T-cell Lymphomas

F. Cabanillas, J. Cox, R. Wilder, 2002, Leukemia & lymphoma.

Unique approaches for testicular shielding during total‐body irradiation for pediatric patients

N. Kirby, C. Ha, P. Papanikolaou, 2022, Journal of applied clinical medical physics.

Results o f T reatment W ith H yper-CVAD, a D ose-Intensive Regimen, i n A dult A cute L ymphocytic L eukemia

M. Andreeff, H. Kantarjian, J. Cortes, 2000 .

Resul ts of Treatment With Hyper-CVAD , a Dose-Intens ive Regimen , in Adul t Acute Lymphocyt ic Leukemia

M. Andreeff, H. Kantarjian, J. Cortes, 2000 .

MDM2 restrains estrogen-mediated AKT activation by promoting TBK1-dependent HPIP degradation

Tong Xu, J. Little, J. Asara, 2014, Cell Death and Differentiation.

Non-Hodgkin's Lymphomas Involving the Uterus: A Clinicopathologic Analysis of 26 Cases

M. Deavers, L. Medeiros, R. Vang, 2000, Modern Pathology.

Prevention of Diagnostic and Treatment-Related Sequelae in Stage I and II Hodgkin´s Disease

J. Cox, C. Ha, J. Cox, 1999 .

Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.

Z. Liao, S. Tucker, J. Cox, 2001, International journal of radiation oncology, biology, physics.

Long-term results with radiotherapy for Stage I-II follicular lymphomas.

S. Tucker, L. Fuller, P. Mclaughlin, 2001, International journal of radiation oncology, biology, physics.

Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.

P. Mclaughlin, F. Cabanillas, J. Cox, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary C utaneous N on-Hodgkin's L ymphoma o f A nn A rbor Stage I : P referential C utaneous R elapses b ut H igh C ure Rate W ith D oxorubicin-Base d T herapy

P. Mclaughlin, J. Cox, F. Cabanillas, 2001 .

ACR Appropriateness Criteria: Localized nodal indolent lymphoma.

R. Advani, C. Flowers, L. Constine, 2013, Oncology.

LOCALIZED NODAL INDOLENT LYMPHOMA

R. Advani, C. Flowers, L. Constine, 2013 .

The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).

S. Tucker, P. Mclaughlin, J. Cox, 2001, International journal of radiation oncology, biology, physics.

Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.

Terry L. Smith, L. Fuller, P. Mclaughlin, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.

P. Mclaughlin, J. Cox, F. Cabanillas, 1998, Blood.

Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma

F. Cabanillas, J. Cox, R. Wilder, 2001, Cancer.

ACR appropriateness criteria follow-up of Hodgkin lymphoma.

R. Advani, Sonali M. Smith, C. Flowers, 2014, Journal of the American College of Radiology : JACR.

Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.

S. Tucker, J. Cox, F. Cabanillas, 2003, International journal of radiation oncology, biology, physics.

The role of local radiation therapy for mediastinal disease in adults with T‐cell lymphoblastic lymphoma

H. Kantarjian, J. Cortes, J. Cox, 2002, Cancer.

Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone

J. Cox, R. Wilder, D. Weber, 2002, Cancer.

Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.

C. Pelloski, J. Cox, F. Cabanillas, 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.

S. Tucker, J. Cox, F. Cabanillas, 2000, International journal of radiation oncology, biology, physics.

Localized primary malignant lymphoma of bone.

J. Murray, L. Fuller, J. Cox, 1997, International journal of radiation oncology, biology, physics.

The effect of radiation therapy on post-prostatectomy urinary function.

S. Jhavar, G. Swanson, C. Ha, 2020, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Low-dose Arsenic induces chemotherapy protection via p53/NF-κB-mediated metabolic regulation

Zhi-Min Yuan, S. Ganapathy, S. Seo, 2013, Oncogene.

The effects of treatment duration on outcomes of radiation treatment with high-dose-rate brachytherapy in the era of concurrent chemoradiation for cervical carcinoma

C. Ha, T. Eng, N. Wandrey, 2018, Journal of Radiation Oncology.

Incidence of gastric involvement in patients with nongastrointestinal extranodal marginal zone lymphoma

Christine F. Wogan, P. Allen, L. Medeiros, 2011, Cancer.

Multiple myeloma of the cervical spine: treatment strategies for pain and spinal instability.

G. Rao, E. Mendel, L. Rhines, 2006, Journal of neurosurgery. Spine.

ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma

R. Advani, Sonali M. Smith, C. Flowers, 2015, American journal of clinical oncology.

Outcomes of patients undergoing radiation therapy for bladder cancer

G. Swanson, C. Ha, E. Galvan, 2018, Bladder.

Dosimetric effect of photon beam energy on volumetric modulated arc therapy treatment plan quality due to body habitus in advanced prostate cancer.

N Papanikolaou, G. Swanson, N. Papanikolaou, 2015, Practical radiation oncology.

Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.

S. Tucker, J. Cox, F. Cabanillas, 2001, International journal of radiation oncology, biology, physics.

Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma

S. Tucker, F. Cabanillas, J. Cox, 2002, Cancer.

ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.

R. Advani, Sonali M. Smith, C. Flowers, 2016, American journal of clinical oncology.

Salvage central lymphatic irradiation in follicular lymphomas following failure of chemotherapy: a feasibility study.

S. Tucker, J. Cox, F. Cabanillas, 1999, International journal of radiation oncology, biology, physics.

European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte‐predominant Hodgkin disease

J. Cox, F. Cabanillas, A. Younes, 2002, Cancer.

Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity

S. Tucker, J. Cox, B. Andersson, 2001, Cancer.

Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American radium society appropriate use criteria

R. Advani, Sonali M. Smith, C. Flowers, 2020, Leukemia & lymphoma.

Radiotherapy Alone for Lymphocyte‐Predominant Hodgkin's Disease

J. Cox, F. Cabanillas, A. Younes, 2002, Cancer journal.

Radiation therapy for malignant lymphoma: enduring importance in the era of systemic therapy.

J. Cox, R. Wilder, C. Ha, 2001, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

An elevated serum beta‐2‐microglobulin level is an adverse prognostic factor for overall survival in patients with early‐stage Hodgkin disease

S. Tucker, J. Cox, F. Cabanillas, 2002, Cancer.

Making good results even better: The evolving role of radiotherapy in patients with early diffuse large B-cell lymphoma

C. Ha, 2013 .

Treatment and Outcomes of Primary Urethra Cancer

C. Ha, T. Eng, Abhilasha Patel, 2017, American journal of clinical oncology.

Rectal and bladder dose reduction with the addition of intravaginal balloons to vaginal packing in intracavitary brachytherapy for cervical cancer.

C. Ha, T. Eng, A. Patel, 2016, Brachytherapy.

Clinical implications of incorporating heterogeneity corrections in mantle field irradiation.

R. Kudchadker, J. Cox, K. Prado, 2003, International journal of radiation oncology, biology, physics.

Primary non-Hodgkin lymphoma of the large bowel.

L. Fuller, J. Cox, P. Allen, 1997, Radiology.

Multi-Center US Intergroup Study of Intensive Chemotherapy Plus Dasatinib Followed By Allogeneic Stem Cell Transplant in Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Younger Than 60

J. Radich, F. Appelbaum, H. Kantarjian, 2015 .

Tolerance of Phellodendron amurense Bark Extract (Nexrutine®) in Patients with Human Prostate Cancer

G. Swanson, Addanki P. Kumar, J. Basler, 2015, Phytotherapy research : PTR.

p53‐Based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study

J. Michalek, R. Elledge, G. Swanson, 2016, Molecular Oncology.

Screening logs from a pilot randomized controlled trial of radical cystectomy versus chemoradiation therapy for muscle-invasive bladder cancer.

R. Svatek, D. Pruthi, M. Liss, 2020, Urologic oncology.

A Low-dose Arsenic-induced p53 Protein-mediated Metabolic Mechanism of Radiotherapy Protection*

J. Little, Zhi-Min Yuan, S. Ganapathy, 2014, The Journal of Biological Chemistry.

RECURRENT HODGKIN LYMPHOMA Expert Panel on Radiation Oncology

Leslie, Mendenhall, C. Flowers, 2016 .

Radiotherapy and Hodgkin's lymphoma.

J. Cox, P. Das, C. Ha, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression.

Z. Liao, P. Mclaughlin, J. Manning, 2000, International journal of radiation oncology, biology, physics.

Malt (mucosa associated lymphoid tissue) lymphoma with supradiaphragmatic presentation: Natural history and patterns of failure

Z. Liao, P. Mclaughlin, J. Manning, 1998 .

Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1996-1997.

S. Tucker, L. Fuller, J. Cox, 1998, Radiology.

Allogeneic Transplantation after an Alemtuzumab-Containing Myeloablative Conditioning Regimen for CD52 Positive Acute Lymphoblastic Leukemia (ALL).

M. Qazilbash, D. Couriel, R. Champlin, 2005 .

Correlation of gallium-67 SPECT and CT findings in primary gynecologic lymphoma.

E. Kim, C. Ha, J. Kim, 1999, Clinical imaging.

Persistent Disparities in Hispanics with Cervical Cancer in a Major City

C. Ha, T. Eng, Abhilasha Patel, 2013, Journal of Racial and Ethnic Health Disparities.

Hodgkin's disease: correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with Stage I supradiaphragmatic presentations vs. those in patients with Stage II.

L. Fuller, L. North, F. Cabanillas, 1998, International journal of radiation oncology, biology, physics.

International prognostic index‐based outcomes for diffuse large B‐cell lymphomas

S. Tucker, F. Cabanillas, L. Medeiros, 2002, Cancer.

Primary Mediastinal B cell Lymphoma in the Positron-Emission Tomography Era Executive Summary of the American Radium SocietyTM Appropriate Use Criteria.

R. Advani, Sonali M. Smith, C. Flowers, 2021, International journal of radiation oncology, biology, physics.

ACR Appropriateness Criteria s Hodgkin Lymphoma—Unfavorable Clinical Stage I and II